These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21586427)

  • 1. Controversies with On-TIME 2.
    Lin GM; Li YH; Chu KM; Han CL
    Heart; 2011 Jun; 97(12):1026; author reply 1026. PubMed ID: 21586427
    [No Abstract]   [Full Text] [Related]  

  • 2. IIb or Not IIb: is there a place for pre-hospital tirofiban in ST-segment elevation myocardial infarction patients?
    Waksman R
    J Am Coll Cardiol; 2010 Jun; 55(22):2456-8. PubMed ID: 20510212
    [No Abstract]   [Full Text] [Related]  

  • 3. High-dose tirofiban pretreatment reduces the need for bail-out study medication in patients with ST-segment elevation myocardial infarction: results of a subgroup analysis of the On-TIME 2 trial.
    Hermanides RS; Heestermans AA; Ten Berg JM; Gosselink AT; Ottervanger JP; van Houwelingen KG; Kolkman JJ; Stella PR; Dill T; Hamm C; van 't Hof AW
    Heart; 2011 Jan; 97(2):106-11. PubMed ID: 20962338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upstream glycoprotein IIb/IIIa inhibitors for STEMI: use on-time or not at all?
    Seto A; Kern MJ
    Catheter Cardiovasc Interv; 2012 May; 79(6):965-6. PubMed ID: 22511381
    [No Abstract]   [Full Text] [Related]  

  • 5. Prehospital high-dose tirofiban in patients undergoing primary percutaneous intervention. The AGIR-2 study.
    El Khoury C; Dubien PY; Mercier C; Belle L; Debaty G; Capel O; Perret T; Savary D; Serre P; Bonnefoy E;
    Arch Cardiovasc Dis; 2010 May; 103(5):285-92. PubMed ID: 20619238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycoprotein IIb/IIIa receptor blockers in acute coronary syndromes.
    Störk T; Fröhlich E; Möckel M
    Lancet; 2001 Dec; 358(9297):1996-7. PubMed ID: 11747950
    [No Abstract]   [Full Text] [Related]  

  • 7. Glycoprotein IIb/III inhibition during acute percutaneous coronary intervention: tool or talisman?
    El-Jack S
    J Interv Cardiol; 2013 Aug; 26(4):340-2. PubMed ID: 23941651
    [No Abstract]   [Full Text] [Related]  

  • 8. Exit of platelet glycoprotein-IIb/IIIa-receptor inhibitors?
    Adam PC; Pemberton J; Evemy KL
    Lancet; 2001 May; 357(9267):1535-6. PubMed ID: 11386297
    [No Abstract]   [Full Text] [Related]  

  • 9. AMI on the move.
    Valgimigli M
    EuroIntervention; 2011 Aug; 7(4):415, 417, 419. PubMed ID: 21764657
    [No Abstract]   [Full Text] [Related]  

  • 10. Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial.
    Van't Hof AW; Ten Berg J; Heestermans T; Dill T; Funck RC; van Werkum W; Dambrink JH; Suryapranata H; van Houwelingen G; Ottervanger JP; Stella P; Giannitsis E; Hamm C;
    Lancet; 2008 Aug; 372(9638):537-46. PubMed ID: 18707985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of early, pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short- and long-term clinical outcome.
    ten Berg JM; van 't Hof AW; Dill T; Heestermans T; van Werkum JW; Mosterd A; van Houwelingen G; Koopmans PC; Stella PR; Boersma E; Hamm C;
    J Am Coll Cardiol; 2010 Jun; 55(22):2446-55. PubMed ID: 20510211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The golden hour of prehospital reperfusion with triple antiplatelet therapy: a sub-analysis from the Ongoing Tirofiban in Myocardial Evaluation 2 (On-TIME 2) trial early initiation of triple antiplatelet therapy.
    Heestermans T; van 't Hof AW; ten Berg JM; van Werkum JW; Boersma E; Mosterd A; Stella PR; van Zoelen AB; Gosselink AT; Kochman W; Dill T; Koopmans PC; van Houwelingen G; Zijlstra F; Hamm C
    Am Heart J; 2010 Dec; 160(6):1079-84. PubMed ID: 21146661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of pre-hospital glycoprotein IIb-IIIa inhibitors on angiographic outcome in STEMI patients who are candidates for primary PCI.
    Hermanides RS; van Werkum JW; Ottervanger JP; Breet NJ; Gosselink AT; van Houwelingen KG; Dambrink JH; Hamm C; ten Berg JM; van 't Hof AW;
    Catheter Cardiovasc Interv; 2012 May; 79(6):956-64. PubMed ID: 22162050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upstream treatment of ST-segment elevation myocardial infarction: the role of glycoprotein IIb/IIIa inhibitors.
    Joyal D; Eisenberg MJ
    Can J Cardiol; 2011; 27(5):534-5. PubMed ID: 21775098
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanical reperfusion: treat well, treat on time too.
    Montalescot G
    Lancet; 2008 Aug; 372(9638):509-10. PubMed ID: 18707968
    [No Abstract]   [Full Text] [Related]  

  • 16. Direct intracoronary delivery of tirofiban during primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Shen WF
    Chin Med J (Engl); 2012 Jan; 125(1):3-6. PubMed ID: 22340456
    [No Abstract]   [Full Text] [Related]  

  • 17. Higher efficacy of pre-hospital tirofiban with longer pre-treatment time to primary PCI: protection for the negative impact of time delay.
    Heestermans T; de Boer MJ; van Werkum JW; Mosterd A; Gosselink AT; Dambrink JH; van Houwelingen G; Koopmans P; Hamm C; Zijlstra F; ten Berg JM; van 't Hof AW
    EuroIntervention; 2011 Aug; 7(4):442-8. PubMed ID: 21764662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of early high-loading-dose tirofiban on platelet activity in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
    Ren XN; Wang LF; Wang MS; Xu L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Feb; 40(2):131-5. PubMed ID: 22490713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IC bolus only versus IV with infusion 2b/3a inhibitors during STEMIs having PCI.
    Chilton R
    Catheter Cardiovasc Interv; 2012 Jan; 79(1):68-9. PubMed ID: 22190206
    [No Abstract]   [Full Text] [Related]  

  • 20. Abciximab, eptifibatide, and tirofiban: comparison of parenteral glycoprotein IIb/IIIa inhibitors.
    Dunn A
    Conn Med; 1999 Aug; 63(8):483-7. PubMed ID: 10500344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.